Agenda item

Presentation by the Chief Officer, NHS Tees Valley Clinical Commissioning Group

The Chief Officer, Tees Valley Clinical Commissioning Group gave a presentation (previously circulated) providing Members with an update on the development of the Integrated Care System (ICS).

The presentation outlined the engagement with local authorities to develop the ICS which included one-to-one meetings with the ICS Chair, council leaders and executives,Joint Management Executive Meetings, which were held throughout October-November to develop proposals on the ICS governance and operating model, ongoing engagement with local and regional scrutiny meetings and engagement on the Integrated Care Board (ICB) Constitution.

Reference was made to the current CCG statutory duties and powers; the existing structures for the eight CCG’s in the North East and North Cumbria; and the current CCG commissioning spend in the ICS area.

Members were provided with details of the potential distribution of the ICS functions at both a System and Place level; particular reference was made to joint work between NHS and Local Authorities including participation in Health and Wellbeing Boards to develop Joint Strategic Needs Assessments and Joint Health and Wellbeing Strategies, joint initiatives to promote health, prevent disease and reduce inequalities and joint commissioning and leadership of local services. Members also noted the governance options for place based partnerships and that the ICB would be in place by June 2022.

The presentation outlined the core elements of the ICB governance arrangements; governance features of the ICB; and that membership had been proposed to NHS England in December 2021, with 25 voting Members, 13 non-executive and 12 executive, with a commitment to review after one year.

Members were informed of the requirement to establish an Integrated Care Partnership (ICP) alongside the ICB; the ICP would have a key role to play in setting the tone and culture of the system, operating a collective model of accountability, including to local residents; and the ICP was required to mutually agree terms of reference, membership, ways of operating and administration. Reference was made to the four ICP’s in the North East and North Cumbria ICS; and the Chief Executive Officer designate and ICB Chair designate had been appointed.

Discussion ensued regarding concern in respect of the scale of the management structure;  the importance of engaging with place; and engagement opportunities with regional and local scrutiny committees.

RESOLVED – That the Chief Officer, Tees Valley Clinical Commissioning Group be thanked for his informative presentation.